Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 210 Records) |
| Query Trace: Lung Neoplasms and Pik3ca[original query] |
|---|
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohort. Lung cancer (Amsterdam, Netherlands) 2022 9 173 71-74. Lim Guan Hui Tricia, Balbi Kevin Jon, Poskitt Benjamin, Bennett Philip, Moore David All |
| Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions. Frontiers in oncology 2022 12 952572. Qiu Yuan, Liu Liping, Yang Haihong, Chen Hanzhang, Deng Qiuhua, Xiao Dakai, Lin Yongping, Zhu Changbin, Li Weiwei, Shao Di, Jiang Wenxi, Wu Kui, He Jianxi |
| Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 2022 Jun 29 (7): 4428-4437. Kuang Shelley, Fung Andrea S, Perdrizet Kirstin A, Chen Kaitlin, Li Janice J N, Le Lisa W, Cabanero Michael, Karsaneh Ola Abu Al, Tsao Ming S, Morganstein Josh, Ranich Laura, Smith Adam C, Wei Cuihong, Cheung Carol, Shepherd Frances A, Liu Geoffrey, Bradbury Penelope, Pal Prodipto, Schwock Joerg, Sacher Adrian G, Law Jennifer H, Stockley Tracy L, Leighl Natasha |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma. Molecular and cellular probes 2022 5 64 101819. Cine Naci, Ali Sen Emin, Demir Gulhan, Gokbayrak Merve, Guzdolu Eda, Sertdemir Nilufer, Aydin Duygu, Kurtas Omer, Reka Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Uygun Kazim, Cabuk Devrim, Gorkem Aksu Maksut, Zafer Canturk Nuh, Savli Hak |
| Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models. Therapeutic advances in medical oncology 2022 3 14 17588359221079125. Lim Sun Min, Yang San-Duk, Lim Sangbin, Heo Seong Gu, Daniel Stetson, Markovets Aleksandra, Minoo Rafati, Pyo Kyoung-Ho, Yun Mi Ran, Hong Min Hee, Kim Hye Ryun, Cho Byoung Ch |
| The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patients. Journal of thoracic disease 2022 Jan 14 (1): 185-193. Zhang Yi, Li Shirong, Lyu Zhi, Cai Jinghuang, Zheng Naishan, Li Yanping, Xu Tianwen, Zeng Huiqi |
| Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes. Journal of personalized medicine 2022 3 12 (3): . Pop-Bica Cecilia, Ciocan Cristina Alexandra, Braicu Cornelia, Harangu? Antonia, Simon Marioara, Nutu Andreea, Pop Laura Ancuta, Slaby Ondrej, Atanasov Atanas G, Pirlog Radu, Al Hajjar Nadim, Berindan-Neagoe Ioa |
| A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma. Translational lung cancer research 2022 3 11 (2): 238-249. Chen Ying, Xu Jinhe, Zhang Lei, Song Yingfang, Wen Wen, Lu Jun, Zhao Zhongquan, Kong Wencui, Liu Wei, Guo Aiping, Santarpia Mariacarmela, Yamada Tadaaki, Cai Xiuyu, Yu Zongya |
| Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 2022 2 6 e2100424. Krop Ian E, Jegede Opeyemi A, Grilley-Olson Juneko E, Lauring Josh D, Mitchell Edith P, Zwiebel James A, Gray Robert J, Wang Victoria, McShane Lisa M, Rubinstein Larry V, Patton David, Williams P Mickey, Hamilton Stanley R, Kono Scott A, Ford James M, Garcia Agustin A, Sui Xingwei D, Siegel Robert D, Slomovitz Brian M, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort. Translational cancer research 2022 2 8 (1): 255-261. Wang Zeng, Jiang Zhiming, Lu Hongya |
| The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer. Translational cancer research 2022 2 8 (1): 170-179. Lin Xiao, Dong Wentao, Lai Xiaojing, Feng Wei, Yu Xiaofu, Gu Qing, Wang Chunyang, Xiao Wen, Zheng Xi |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (2): 169-180. Bar Jair, Peled Nir, Schokrpur Shiruyeh, Wolner Mirjana, Rotem Ofer, Girard Nicolas, Aboubakar Nana Frank, Derijcke Sofie, Kian Waleed, Patel Sandip, Gantz-Sorotsky Hadas, Zer Alona, Moskovitz Mor, Metro Giulio, Rottenberg Yakir, Calles Antonio, Hochmair Maximilian, Cuppens Kristof, Decoster Lynn, Reck Martin, Limon Dror, Rodriguez Estelamari, Astaras Christoforos, Bettini Adrienne, Häfliger Simon, Addeo Alfre |
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PloS one 2022 17 (10): e0276161. Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L |
| PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC cancer 2022 Oct 22 (1): 1066. Kojima Kensuke, Imai Saki, Samejima Hironobu, Fujiwara Ayako, Tokunaga Toshiteru, Yoon Hyungeun, Okishio Kyoic |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. Journal of thoracic disease 2023 8 15 (7): 3811-3817. Ashleigh Poh, Abdelaziz Sammour, Jared Mathai, Joanne Peverall, Chris Van Vliet, Khashayar Asadi, Sagun Para |
| Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results. ESMO open 2023 6 8 (4): 101580. E B Garon, M Reck, K Nishio, J V Heymach, M Nishio, S Novello, L Paz-Ares, S Popat, S Ponce Aix, H Graham, B D Butts, C Visseren-Grul, K Nakagawa, |
| Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023 6 14 (6): . Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun K |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 3 178 229-236. Daher Sameh, Zer Alona, Tschernichovsky Roi, Yacobi Rinat, Barshack Iris, Tsabari Shani, Rottenberg Yakir, Zick Aviad, Gottfried Teodor, Lobachov Anastasiya, Marom Edith M, Urban Damien, Saad Akram, Gantz-Sorotsky Hadas, Onn Amir, Bar Ja |
| Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel. Journal of thoracic disease 2023 1 14 (12): 4669-4684. Zhao Jing, Wu Yang, Chen Min-Jiang, Xu Yan, Zhong Wei, Wang Meng-Zh |
| Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution. Heliyon 2023 1 8 (12): e12374. Yang Hainan, Wen Lei, Zhao Chao, Chen Jianing, Zhou Zhaoming, Zhou Cheng, Cai Linbo, Zhou Caic |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: